NO20012765D0
(no )
2001-06-05
Karboksylsyrer og karboksylsyreisosterer av N-heterosykliske forbindelser
EA200500007A1
(ru )
2006-06-30
Пролекарства возбуждающих аминокислот
BG105012A
(en )
2001-08-31
N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic isosteres
WO2006037982A3
(en )
2006-08-17
Modulators of crth2 receptor activity for the treatment of prostaglandin d2 mediated diseases
WO2004041258A8
(fr )
2005-06-23
Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
WO2006021000A3
(en )
2006-06-15
Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
PL1853232T3
(pl )
2010-01-29
Trwałe postaci krystaliczne mesylanu bifeprunoksu, postaci dawkowania oraz sposoby ich stosowania
EP1802321A4
(en )
2009-12-02
COMPOSITIONS AND METHODS FOR MODULATING PGC-1-ALPHA FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND DISORDERS
WO2010017343A3
(en )
2010-05-14
Flupirtine hydrochloride maleic acid cocrystal
WO1999062879A8
(en )
2000-05-04
Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
ATE494903T1
(de )
2011-01-15
Verwendung von slurp-1 zur behandlung von krankheiten, die durch störungen der acetylcholinerezeptoren ausgelöst werden
TW200621711A
(en )
2006-07-01
3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I ε
TW200600512A
(en )
2006-01-01
Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
WO2004046077A8
(en )
2005-05-19
A method for preparing indan-1,3-dicarboxylic acid
WO2007076131A3
(en )
2007-11-15
Compositions comprising polycation-complexed protein crystals and methods of treatment using them
EP1597234A4
(en )
2007-11-21
NEW COMPOUNDS
ATE409469T1
(de )
2008-10-15
Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen
ATE350034T1
(de )
2007-01-15
Verwendung von epothilone zur behandlung hyperparathyreoidismus
TW200833674A
(en )
2008-08-16
Prodrugs of excitatory amino acids